The comparative protective effect of SM (200 mg/kg P.O daily), COL (0.1 mg/kg P.O daily) and mixture of SM and COL (200 mg/kg and 0.1 mg/kg P.O daily respectively) each given for 28 days on the CCl 4 liver fibrosis were studied. Collagen content in livers of animals treated with CCl 4 was increased compared to control and histopathological examination of liver samples by Masson's Trichome stain (MTC) showed that collagen accumulated in the portal area resulting in the formation of fibrotic tissues. SM has shown a significant recovered enzyme activities in all the changes observed in LF induced by CCl 4 rats, except for serum total cholesterol and serum alkaline phosphatase which were reduced only 35% and 80% respectively as compared with CCl 4 treated rats. The mixture of SM & COL was more potent in the hepato-protection than COL only, but SM was the best hepatoprotective drug.
Introduction
The main causes of liver diseases are viral, autoimmune, drug/toxin, alcohol and nonalcoholic fatty liver disease (Pinzani and Rombouts, 2004) . Liver damage goes through several stages which are fatty liver, liver fibrosis and liver cirrhosis. LF defined as the reversible wound-healing process that occurs as a result of a repeated injury and wide range of inflammatory reactions in the liver (Mera et al., 2014). LF results from chronic damage to the liver in conjunction with the excessive accumulation of extracellular matrix proteins including collagen (Seki et al., 2009). Early stages of fibrosis are reversible either by removal of the specific stimulus or by treatment with antifibrotic medications, whereas late stages, progressing to cirrhosis are less reversible (Ellis and Mann, 2012). CCl 4 induced hepatic injury as it used as experimental model for anti-inflammatory and hepatoprotective drug screening, promoting hepatic pathology similar to that observed in humans (Li et al., 2013) . Acute administration of a large dose of CCl 4 causes severe necrosis, while chronic administration of lower doses of CCl 4 frequently used to induce LF (Risal et al., 2012) . SM used to regenerate liver cells damaged by alcohol or drugs, protect against industrial poisons, such as CCl 4 (Catalina et al., 2003) . Also, SM has an activity against lipid peroxidation as a result of free radical scavenging and the ability to increase the cellular content of GSH. In addition to its ability to regulate membrane permeability and to increase membrane stability in the presence of xenobiotic damage. SM inhibits the transformation of stellate hepatocytes into myofibroblasts, which are responsible for the deposition of collagen fibers leading to cirrhosis. COL effectively inhibits collagen synthesis and fibrosis in experimental animal models; COL is used in the following cases: primary biliary cirrhosis and alcoholic cirrhosis (Rodriguez et al., 1998). COL protects the liver of experimental animals against several hepatotoxins and inhibits polymerization of microtubules, a process that is believed to be required for collagen secretion. Thus, it is believed to work as an antifibrotic compound by two ways; the first is inhibition of the cellular secretion of procollagen leading to its intracellular accumulation (Mosnier et al., 1991), the second a stimulation of collagenase activity (Hellstrom and Bivalacqua, 2000) .
Materials and Methods

Animals
Female albino rats obtained from the animal house of the Institute of Ophthalmology (Giza, Egypt). The animals acclimatized for period of two weeks to adapt themselves with the new location at the animal house. They housed under appropriate conditions of controlled humidity, temperature and light with free access to water and standard pellet rat diet. All animals received human care in compliance with the state authorities following the Egyptian rules of animal protection.
Chemicals
All chemicals from analytical and purified grade provided from Sigma-Aldrich Company. (St. Louis USA), El-Gomhoreya Chemical Co. (Cairo, Egypt), Merck (Darmstadt, Germany) and MUP "Medical Union Pharmaceuticals" (Ismailia, Egypt).
Design of the work
A total of fifty five female albino rats (140-180 g) randomly divided into the five groups. Duration of the experiment was twenty eight days. The groups distributed as follows: Control group: rat injected with 2 ml/kg corn oil I.P twice weekly for four weeks and given 2 ml D.W daily P.O. Rats injected with CCL 4 : rats injected with 2 ml/kg CCl 4 I.P, dissolved in corn oil 
Measuring parameters
Physical parameters
Organ index (liver & spleen) calculated as follows: Organ index = (organ weight/ rat body weight) X 100 (Yang et al., 2005) .
Biochemical serum analysis
At the end of experiment, fasted rats anesthetized by diethyl ether. Blood samples obtained from the retro-orbital junction. All photometric measurements carried out using Shimadzu spectrometer UV-1201 (Japan). Serum Tests: Total cholesterol (Watson, 1960) , the activity of alanine aminotransaminase (ALT) activity & aspartate aminotransaminase (AST) activity (Reitman and Frankel 1957) , alkaline phosphatase (ALP) activity (Belfield and Goldberg, 1971) , direct bilirubin (DB) and total bilirubin (TB) (Doumas et al., 1985) .
Biochemical assay of liver homogenate
The liver was dissected, weighted. Tissue homogenates (20% w/v) made by homogenization with saline for one minute using TRI-R, homogenizer. Tubes centrifuged at 3000 rpm for 15 minutes. Assessment of fibrosis markers in Hydroxyproline (HP) content (Reddy and Enwemeka 1996) . Assessment of oxidative stress markers as determination of catalase (CAT) activity ( (Claiborne, 1985) , determination of superoxide dismutase (SOD) (Minami and Yoshikawa 1979), determination of glutathione-s-transferases (GST) (Habig et al., 1974) , determination of reduced glutathione (GSH) (Beutler, 1963) and determination of malondialdehyde (MDA) content (Uchiyama and Mihara, 1978).
Histopathological examination
Hematoxylin and Eosin (H&E) for routine histological examination, Masson's Trichome stain (MTC) for fibrosis markers (Bancroft and Gamble, 2008).
Statistical analysis
All data expressed as mean ± standard error of mean (χ¯±SEM). Descriptive statistics were performed using Microsoft Excel 2010. All analysis & graphics were performed using Graph pad prism (windows version 5; Graph pad software 2007). Difference between means was assessed by ANOVA test. Differences were considered statistically significant at P < 0.05.
Results
The clinical characteristics as difference of body weight (BW), liver & spleen index as well as the serum levels of (ALT, AST, TC, ALP, DB & TB), hepatic homogenate (HP, MDA, SOD, GSH, GST & CAT) of the studied subjects will be showed in Tables (1, 2) .
Concerning, the TC as shown in figure (1) Additionally, the liver and spleen index as shown in figure (10) were significantly higher in all CCL 4 treated groups comparing to normal one. Also they were significantly lower in SM+CCl 4, COL+CCl 4 & SM+COL+CCl 4 groups comparing to CCl 4 alone treated group. The Histopathological liver examination: Hematoxylin and Eosin (H&E) for routine histological examination will be showed in Fatty change
Where (+++) for severe with range 75-100%, (++) for moderate with range 50-75%, (+) for mild with range 25-50% and (-) for Nil with range 0-25%. This study showed H&E liver staining in SM group, showed a moderate fatty change in few hepatocytes only, and so SM protect the liver from necrosis, so it is considered an anti-inflammatory drug. Also, COL group, showed a mild dilatation and congestion in central and portal veins with few inflammatory cells infiltration in the portal area, so SM protect the liver from necrosis, so it is considered an antiinflammatory drug. Finally, the mixture of SM+COL, showed a mild fatty change in few hepatocytes. This study showed MTC, in CCl 4 group showed extensive accumulation of connective tissues resulting in the formation of continuous fibrotic septa, nodules of regeneration and noticeable alterations to the central veins, compared to those of the healthy controls. COL protected liver tissues, showed a reduced collagen deposition. SM only and the mixture of both COL+SM protected tissues, showed a negative collagen deposition.
Discussion
The liver damage produced by the administration of CCl 4 , was evidenced by the characteristic pattern of histological and biochemical alterations. Both COL & SM significantly prevented the serum, liver homogenates & histological alterations induced by CCl 4 . The presence of LF was evidenced by histological and biochemical determinations in liver tissues. COL given at the dose of 0.1mg/kg rat' day' along with CCl 4 partially inhibits collagen synthesis. COL has an antifibrogenic effect and significantly reduced the amount of collagen as compared to that found in rats receiving CCl 4 only. Also, SM co-treatment partially prevents CCl 4 induced LF.
Hydroxyproline levels in tissue hydrolysates are a direct measure of the amount of collagen present (Colgrave et al., 2012) . The present study showed a significantly increased hepatic HP content in the (CCL 4 , COL+CCl 4 & SM+COL+CCl 4 ) groups when compared with the control group. This study was in agreement with those of (Yang et al., 2012 ) whom reported that increased expression of hepatic HP is another liver index that represents the degree of LF. Also, the present study showed a significantly decreased hepatic HP content in the (SM, COL and the mixture of SM & COL) groups when compared with the CCL 4 group. This study was in agreement with (Li et al., 2011) .
Our data revealed that CCl 4 treatment significantly increased levels of MDA and decreased levels of SOD, CAT, GSH & GST activities in liver tissues. These results were similar to the previous reports (Breikaa et al., 2013) . Administration of COL or SM also prevented the increase in liver peroxidation caused by CCI 4 . Lipid peroxidation is one of the primary events of CC1 4 induced liver damage (HernandezGea and Friedman, 2011). The changes produced by CCl 4 , in the plasma membrane structure and stability are associated with alterations in its lipid composition and these changes are followed by the increases in lipid peroxidations produced by its free radical metabolites. The total protection against MDA increase could be an effect of COL on plasma membrane of the hepatocytes.
The overproduction of ROS in hepatocytes may cause cell death by damaging DNA, proteins, lipids and carbohydrates ( This study showed H&E liver staining in a control group of rats showed a normal architecture with both central and portal veins. Also, H&E for liver examination of CCl 4 exposed rats resulted in moderate necrosis in hepatic parenchyma; severe fatty changes; mild dilatation in central and portal veins as well as inflammatory cells infiltration; fibrosis and degenerative changes in the portal area. These results are in agreement with (Turkdogan et al., 2003) .
In conclusion, our findings indicate that SM & COL drugs have potent antifibrotic activities. These results were in agreement with (Kershenobich et al., 1988) who reported that COL is thought to act on collagen accumulation in two ways; the first an inhibition of the cellular secretion of procollagen leading to its intracellular accumulation, the second a stimulation of collagenase activity. Our findings also indicate that SM and/or COL may be useful in the protection and prevention of hepatic toxicity in CCl 4 treated rats, recovered enzyme activities in the liver (decreased hepatic damage), improved cellular injuries & also have potent antioxidant activities that might protect the liver and improve the symptoms of liver injuries by scavenging the ROS to overcome the oxidative damage caused by CCl 4 in artificially induced hepatic injury. 
‫المحدث‬ ‫الكبد‬ ‫تليف‬ ‫فى‬ ‫الكولشيسين‬ ‫و‬ ‫السيليمارين‬ ‫من‬ ‫لكل‬ ‫الوقائي‬ ‫التأثير‬ ‫مقارنت‬ ‫دراست‬ ‫الدكاترة‬ ‫للسادة‬
